Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 1, 2013, Pages 100-104

  Carrier, P ^a   Godet, B ^a   Crepin, S ^a   Magy, L ^a   Debette Gratien, M ^a   Pillegand, B ^a   Jacques, J ^a   Sautereau, D ^a   Vidal, E ^a   Labrousse, F ^a   Gondran, G ^a   Loustaud Ratti, V ^a,b  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b UMR 1092   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ACUTE CYTOLYTIC HEPATITIS; ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS; HUMAN; LIVER BIOPSY; LIVER TOXICITY; MEDICAL LITERATURE; MULTIPLE SCLEROSIS; THYROID DISEASE;

ADULT; AUTOIMMUNITY; DRUG-INDUCED LIVER INJURY; FEMALE; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS;

EID: 84873106450     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.10.015     Document Type: Article

References (34)

1. Larrey D. Foie, médicaments et agents chimiques. Gastroenterol Clin Biol 2009, 33:1136-1146.
2. Bégaud B., Evreux J.C., Jouglard J., Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie 1985, 40:111-118.
3. Danan G. Definition et criteres d'imputation des atteintes hepatiques aiguës medicamenteuses. Conclusions d'une reunion internationale de consensus. Gastroenterol Clin Biol 1993, 17:H17-H18.
4. Shigematsu A., Okada K., Abe N., Ota S., Kato N., Kondo K., et al. Non-alcoholic steatohepatitis occurring in a patient with T-lymphoblastic lymphoma during chemotherapy including prednisolone. Leuk Lymphoma 2006, 47:1397-1399.
5. Marino M., Morabito E., Altea M.A., Ambrogini E., Oliveri F., Brunetto M.R., et al. Auto-immune hepatitis during intravenous glucocrticoid pulse therapy for Graves' ophtalmopathy treated sucessfully with glucocorticoids themselves. J Endocrinol Invest 2005, 28(3):280-284.
6. Nagai T., Imamura M., Kamiya Y., Mori M. Graves' disease accompanied by anti-myeloperoxidase antibody-related nephropathy and autoimmune hepatitis. Intern Med 2004, 43(6):516-520.
7. Le Moli R., Baldeschi L., Saeed P., Regensburg N., Mourits M.P., Wiersinga W.M. Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid 2007, 7(4):357-362.
8. Salvi M., Vannucchi G., Sbrozzi F., Del Castello A.B., Carnavelli A., Fargion S., et al. Onset of autoimmune hepatitis during intraveinous steroid therapy for thyroid-associated ophtalmopahty in a patient with Hashimoto's thyroiditis: case report. Thyroid 2004, 14(8):631-634.
9. Weissel M., Hauff W. Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease. Thyroid 2000, 10(6):521.
10. Tremlett H.L., Yoshida E.M., Oger J. Liver injury associated with the beta-interferons for multiple sclerosis: a comparison between the three products. Neurology 2004, 62:628-631.
11. Belniak E., Stelmasiak Z., Papuc E. Multiple sclerosis and other autoimmune diseases. Neurol Neurochir Pol 2007, 41(3):259-266.
12. Maamouri N., Ketari S., Ben Hariz F., Belkahla N., Ben Romdhane S., Chouaib S., et al. Bolus de méthylprednisolone révélant une hépatite auto-immune chez une patiente atteinte de sclérose en plaques. J Afr Hepatol Gastroenterol 2009, 3:195-197.
13. Takahashi A., Kanno Y., Sakamoto N., Monoe K., Saito H., Abe K., et al. Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report. World J Gastroentero 2008, 14(35):5474-5477.
14. Corrieri-Baizeau C., Borel I., Cottin V., Vukusic S., Scoazec J.Y., Audigier J.C., et al. Hépatite auto-immune associée à unesclérose en plaques. Gastroenterol Clin Biol 2004, 28(11):1186-1187.
15. Luth S., Birklein F., Schramm C., Herkel J., Hennes E., Muller-Forell W., et al. Multiplex neuritis in a patient with autoimmune hepatitis: a case report. World J Gastroenterol 2006, 12(33):5396-5398.
16. de Seze J., Canva-Delcambre V., Fajardy I., Delalande S., Stojkovic T., Godet E., et al. Autoimmune hepatitis and multiple sclerosis: a coincidental association. Mult Scler J 2005, 11(6):691-693.
17. Johnson P.J., McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993, 18:998-1005.
18. Topal F., Ozaslan E., Akbulut S., Küçükazman M., Yüksel O., Altiparmak E. Methylprednisolone-induced toxic hepatitis. Ann Pharmacother 2006, 40(10):1868-1871.
19. Das D., Graham I., Rose J. Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis. Indian J Gastroenterol 2006, 25(6):314-316.
20. Rivero Fernandez M., Riesco J.M., Moreira V.F., Moreno A., Lopez San Roman A., Arranz G., et al. Recurrent acute liver toxicity of intravenous methylprednisolone. Rev Esp Enferm Dig 2008, 100(11):720-723.
21. Hofstee H., Nanayakkara P., Stehouwer C. Acute hepatitis related to prednisolone. Eur J Int 2005, 16:209-210.
22. Loraschi A., Banfi P., Mauri M., Sessa F., Bono G., Cosentino M. Hepatotoxicity after high-dose methylprednisolone for demyelinating disease. Clin Neuropharmacol 2010, 33:52-54.
23. Furutama D., Kimura F., Shinoda K., Maeda T., Tanaka T., Ohsawa N. Recurrent high-dose intravenous methylprednisolone succinate pulse therapy-induced hepatopathy in a patient with multiple sclerosis. Med Princ Pract 2011, 20(3):291-293.
24. Dourakis S.P., Sevastianos V.A., Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. Am J Gastroenterol 2002, 97:1074-1075.
25. Lee S.J., Jusko W.J., Salaita C.G., alcalis K.A., Jann M.W., Spratlin V.E., et al. Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition. J Clin Pharmacol 2006, 46(515):Y526.
26. Stacey N.H., Klaassen C.D. Effects of phospholipase A2 inhibitors on diethyl maleate-induced lipid peroxidation and cellular injury in isolated rat hepatocytes. J Toxicol Environ Health 1982, 9:439-450.
27. Akesson A., Akesson B. Hepatotoxic effects of anti-rheumatic drugs in cultured rat hepatocytes. Scand J Rheumatol 1984, 13:198-202.
28. Serrano T., Mitry R.R., Terry C., Lehec S.C., Dhawan A., Hughes R.D. The effects of immunosuppressive agents on the function of human hepatocytes in vitro. Cell Transplant 2006, 15:777-783.
29. Man W.J., White I.R., Bryant D., Bugelski P., Camilleri P., Cutler P., et al. Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat. Proteomics 2002, 2:1577-1585.
30. Madhu C., Maziasz T., Klaassen C.D. Effect of pregnenolone-16 alpha-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice. Toxicol Appl Pharmacol 1992, 115:191Y198.
31. Wolff J.E., Hauch H., Kühl J., Egeler R.M., Jürgens H. Dexamethasone increases hepatotoxicity of MTX in children with brain tumors. Anticancer Res 1998, 18(2895):Y2899.
32. Fujioka T., Murakami M., Niiya T., Aoki T., Murai N., Enami Y., et al. Effect of methylprednisolone on the kinetics of cytokines and liver function of regenerating liver in rats. Hepatol Res 2001, 19:60 Y 73.
33. Tannuri A., Tannuri U., Coelho M., Mello E., Santos N. Effects of immunosuppressants on hepatocyte cell mitosis during liver regeneration in growing animal models of partial hepatectomy. Transplant Proc 2008, 40:1641-1644.
34. Gerolami R., Mambrini P., Barthet M., Jean-Pastor M.J., Salducci J., Grimaud J.C. Acute hepatitis caused by Solupred in a patient with Crohn disease. Gastroenterol Clin Biol 1997, 21(3):236-237.